PMID: 11318881Apr 25, 2001Paper

Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan

Headache
Bengt A J Källén, P E Lygner

Abstract

To evaluate delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. The safety of the use of drugs for migraine during pregnancy is not established. Using the Swedish Medical Birth Registry which contains information on drug use reported by women at the first antenatal visit, 912 infants (born in 905 deliveries) whose mothers had used drugs for migraine were identified, the majority of whom (n = 658) had used sumatriptan. These women differed from the general population of women who had delivered by being older and more often of first parity, but they had similar smoking habits. Slightly more often, the infants were preterm, and they had a birth weight less than 2500 g; neither of these effects were statistically significant. There seemed to be no difference between infants exposed to sumatriptan and those exposed to other drugs used for migraine. No increase in the rate of congenital malformations was seen. The data indicate that use of sumatriptan in early pregnancy does not result in a large increase in teratogenic risk, but do not rule out the possibility of a moderate increase in risk for a specific birth defect.

References

Feb 1, 1978·Postgraduate Medical Journal·G WainscottM Wilkinson
Jun 1, 1990·Scandinavian Journal of Social Medicine·S CnattingiusB Källén
Jun 1, 1988·Journal of Medical Genetics·H E Hughes, D A Goldstein
Sep 7, 1972·The New England Journal of Medicine·T J David
Feb 1, 1997·Neurologic Clinics·S D Silberstein
Dec 17, 1997·Cephalalgia : an International Journal of Headache·F MaggioniG Zanchin
Mar 13, 1999·Obstetrics and Gynecology·B KällénA Aberg
Sep 29, 1999·European Journal of Clinical Pharmacology·A EricsonB Wiholm
Apr 12, 2000·Headache·C OlesenJ Olsen
Apr 1, 1995·Postgraduate Medicine·Stephen D Silberstein

❮ Previous
Next ❯

Citations

Jan 26, 2008·Der Schmerz·H-C DienerV Limmroth
Jun 28, 2003·Current Pain and Headache Reports·Dawn A Marcus
Feb 10, 2007·Current Treatment Options in Neurology·Dawn A Marcus
Sep 11, 2002·Reproductive Toxicology·Bengt A J Källén, Petra Otterblad Olausson
Jul 2, 2010·The New England Journal of Medicine·Elizabeth Loder
Jul 21, 2011·Human Reproduction·Stefan CikosJuraj Koppel
Mar 13, 2002·Obstetrical & Gynecological Survey·Tiffany Von Wald, Anne D Walling
Jan 29, 2008·Therapeutic Drug Monitoring·Offie P SoldinDaniel M O'Mara
Mar 12, 2008·The Neurologist·Rukmini Menon, Cheryl D Bushnell
Jun 27, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies· P S Sándor
Aug 28, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S EversUNKNOWN European Federation of Neurological Societies
Aug 20, 2005·Cephalalgia : an International Journal of Headache·M FioreM R Goldberg
Jan 28, 2009·Cephalalgia : an International Journal of Headache·T P JürgensA May
Nov 17, 2009·Cephalalgia : an International Journal of Headache·K Nezvalová-HenriksenH Nordeng
Jun 28, 2008·BMJ : British Medical Journal·Peter J GoadsbyStephen D Silberstein
Jun 21, 2005·CNS Drugs·Anthony W FoxEgilius L H Spierings
Jul 17, 2003·Headache·Randolph W Evans, Elizabeth W Loder
Apr 21, 2012·Obstetrics and Gynecology International·Archana DixitBhavna Sharma
Dec 25, 2010·Journal of Perinatology : Official Journal of the California Perinatal Association·E M Blair, K B Nelson
Mar 19, 2008·Expert Review of Neurotherapeutics·Dawn A Marcus
May 10, 2013·Expert Review of Clinical Pharmacology·Doodipala Samba Reddy
Apr 6, 2002·Expert Opinion on Pharmacotherapy·Dawn A Marcus
Nov 22, 2007·Expert Opinion on Drug Metabolism & Toxicology·B Lee Peterlin, Alan M Rapoport
Jul 29, 2010·Expert Opinion on Drug Safety·Matteo CassinaMaurizio Clementi
Sep 11, 2002·Expert Opinion on Pharmacotherapy·D A Marcus
Feb 1, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jørn OlsenUlf Bergman
Jan 22, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Giuseppe NappiGrazia Sances
May 18, 2012·The Journal of Headache and Pain·Paola SarchielliGiorgio Zanchin
Oct 7, 2009·Headache·Marianne CunningtonPaige Churchill
Apr 29, 2006·Headache·Kathryn L Adeney, Michelle A Williams
May 12, 2010·Headache·Tobias Kurth, Sonia Hernandez-Diaz
Feb 12, 2002·The American Journal of Medicine·Dara G Jamieson
Oct 12, 2004·Neurologic Clinics·Stephen D Silberstein
May 8, 2016·Drugs·Bengt Källén, Margareta Reis
Mar 31, 2016·British Journal of Clinical Pharmacology·Joanne E GivenHelen Dolk
Aug 19, 2004·The Annals of Pharmacotherapy·Michelle L HilaireSamantha F Eichner
Apr 3, 2015·Cephalalgia : an International Journal of Headache·Ilse F de CooJoost Haan
May 3, 2012·Journal of Pharmacy Practice·Shannon H Williams, Heather A Kehr
Mar 20, 2008·The Annals of Pharmacotherapy·Emily W Evans, Kristin C Lorber
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Aug 2, 2017·Cephalalgia : an International Journal of Headache·Kevin SpielmannChristof Schaefer
Oct 21, 2017·The Journal of Headache and Pain·A NegroUNKNOWN European Headache Federation School of Advanced Studies (EHF-SAS)
Sep 7, 2006·Birth Defects Research. Part A, Clinical and Molecular Teratology·Ferenc BánhidyAndrew E Czeizel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.